+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Device CDMO & CRO Market - Global Forecast 2026-2032- Product Image
Medical Device CDMO & CRO Market - Global Forecast 2026-2032- Product Image
New

Medical Device CDMO & CRO Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6283181
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Medical Device CDMO and CRO Market: Executive Overview

Medical device contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) support product design, prototyping, verification, validation, clinical evidence generation, regulatory submissions, manufacturing, and post-market activities. Demand is shaped by device complexity, tighter quality requirements, distributed supply chains, and the need to move products from concept to commercialization with specialized expertise. The market spans services for implantable, diagnostic, surgical, monitoring, digital, and combination-device programs.

Outsourcing Is Moving Toward Integrated, Risk-Based Partnerships

Medical device developers are increasingly evaluating partners across the full product lifecycle rather than selecting isolated services. Integrated support can reduce handoff risk between design, testing, clinical operations, regulatory work, and production, while enabling earlier identification of technical and compliance issues. At the same time, outsourcing decisions remain risk-based: developers distinguish between strategically sensitive activities retained internally and specialized, capacity-intensive, or highly regulated activities assigned to external providers. Supply-chain resilience, traceability, cybersecurity, process validation, and quality-system maturity are therefore becoming central selection criteria.

Artificial Intelligence Is Improving Design, Evidence, and Operational Control

Artificial intelligence is being applied to design optimization, image and signal analysis, protocol development, patient recruitment, site selection, adverse-event review, document generation, and manufacturing inspection. Its practical value depends on validated datasets, human oversight, explainability, cybersecurity, and controls for software changes and model performance. In medical device development, AI is most useful when embedded within established quality and regulatory processes rather than treated as a standalone productivity tool. Providers that combine domain expertise with controlled data architectures can improve consistency while preserving auditability and patient-safety safeguards.

Regional Insights: Regulation, Capability, and Supply-Chain Priorities Differ

North America combines deep clinical, engineering, and regulatory capabilities with strong demand for advanced devices and outsourced development. Europe emphasizes harmonized quality practices, clinical evidence, sustainability, and compliance across diverse healthcare systems. Asia-Pacific is strengthening design, manufacturing, testing, and clinical capabilities, with regional supply-chain diversification supporting outsourcing activity. Latin America is developing local access to specialized services while managing regulatory and infrastructure variation. The Middle East is investing in healthcare modernization and technology adoption, creating opportunities for localized partnerships and international evidence strategies. Africa presents a more uneven landscape, where market access, infrastructure, procurement conditions, and local clinical capacity strongly influence the feasibility of outsourced programs.

Group Insights: Economic and Security Blocs Shape Partner Selection

ASEAN is relevant for manufacturing diversification, cross-border supply chains, and growing healthcare demand, although regulatory alignment and capability differ among member states. BRICS economies provide substantial engineering, manufacturing, and clinical potential, while geopolitical conditions and national regulatory requirements require careful program planning. The European Union supports cross-border development through common frameworks but still involves country-level operational complexity. G7 markets generally offer mature quality systems, specialized research infrastructure, and demanding compliance expectations. GCC countries are expanding healthcare and advanced-technology capacity, often through international collaboration. NATO economies place additional emphasis on resilience, cybersecurity, dual-use considerations, and secure supply networks.

Country Insights: Capabilities Range from Advanced R&D to Emerging Delivery Hubs

The United States and Canada offer sophisticated device development, clinical research, regulatory, and manufacturing ecosystems. Germany, France, Italy, Spain, and the United Kingdom provide established engineering, clinical, and quality capabilities within distinct national operating environments. Japan and South Korea are strong in precision manufacturing, electronics, diagnostics, and advanced technology, while China combines extensive manufacturing capacity with a large domestic healthcare system and evolving regulatory requirements. India is expanding engineering, clinical, digital-health, and cost-efficient service capabilities. Australia contributes strong clinical research and quality expertise. Brazil and Mexico serve as important Latin American development and manufacturing locations, with country-specific regulatory and infrastructure considerations. Russia’s operating environment is affected by regulatory, geopolitical, trade, and supply-chain constraints that must be assessed program by program.

Actionable Priorities for Medical Device Industry Leaders

Leaders should segment outsourcing decisions by product risk, lifecycle stage, and required technical specialization before selecting partners. They should audit quality systems, design controls, validation practices, cybersecurity measures, data governance, business continuity, and subcontractor oversight. Contracts should define ownership of design history files, clinical data, software assets, deviations, change control, and regulatory responsibilities. A regional operating model can balance access to expertise with resilience, while dual sourcing should be considered for critical components and services. Finally, organizations should establish measurable governance for timelines, evidence quality, inspection readiness, technology performance, and post-market feedback.

Research Methodology: Evidence-Based Market Structuring

This executive summary uses a structured assessment of the medical device CDMO and CRO value chain, covering development, testing, clinical research, regulatory support, manufacturing, and post-market services. Insights are organized by geography and economic or strategic group to identify differences in regulatory maturity, technical capability, infrastructure, and outsourcing conditions. The assessment emphasizes observable industry drivers, operating requirements, and adoption patterns rather than unsupported market estimates. Interpretation should be supplemented with current regulatory documents, public health data, supplier audits, customer interviews, and product-specific due diligence before investment or sourcing decisions.

Conclusion: Capability, Compliance, and Resilience Define Competitive Advantage

The medical device CDMO and CRO landscape is being reshaped by product complexity, evidence requirements, technology integration, and supply-chain risk. Success increasingly depends on partners that can connect engineering, clinical, regulatory, quality, and manufacturing activities while maintaining transparent controls. Artificial intelligence can strengthen these workflows, but only when deployed with validated processes and accountable oversight. Industry leaders that build resilient partner networks, clarify governance, and align regional capabilities with product risk will be better positioned to deliver compliant devices efficiently and safely.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medical Device CDMO & CRO Market, by Integrated Service Offering
7.1. Introduction
7.2. End-to-End CDMO-CRO Services
7.3. Manufacturing + Clinical Services
7.4. Development + Regulatory Services
8. Medical Device CDMO & CRO Market, by Development Stage
8.1. Introduction
8.2. Preclinical Development
8.3. Clinical Trial Support
8.4. Commercial Manufacturing
9. Medical Device CDMO & CRO Market, by Service Type
9.1. Introduction
9.2. Device Design & Engineering
9.3. Clinical Trial Management
9.4. Regulatory Affairs & Submissions
10. Medical Device CDMO & CRO Market, by Therapeutic Area
10.1. Introduction
10.2. Orthopedics
10.3. Cardiovascular
10.4. Neurology
10.5. General Surgery
11. Medical Device CDMO & CRO Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Medical Device CDMO & CRO Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Medical Device CDMO & CRO Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Avania Clinical Services
15.2. Charles River Laboratories International, Inc.
15.3. ClinChoice
15.4. CMIC Group
15.5. Eurofins Scientific
15.6. Fortrea Holdings, Inc.
15.7. ICON plc
15.8. IQVIA Holdings, Inc.
15.9. Medpace Holdings, Inc.
15.10. NAMSA
15.11. Parexel International Corporation
15.12. Proxima CRO
15.13. Qmed
15.14. SGS SA
15.15. Sterling Industries
15.16. Syneos Health, Inc.
15.17. Thermo Fisher Scientific Inc.
15.18. UL Solutions
15.19. WuXi AppTec Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Medical Device CDMO & CRO Market, Years Considered for the Study
FIGURE 2. Global Medical Device CDMO & CRO Market, Research Design
FIGURE 3. Global Medical Device CDMO & CRO Market, Research Framework
FIGURE 4. Global Medical Device CDMO & CRO Market, Data Triangulation
FIGURE 5. Global Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2025 vs 2032 (%)
FIGURE 7. Global Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Medical Device CDMO & CRO Market Size, by Development Stage, 2025 vs 2032 (%)
FIGURE 9. Global Medical Device CDMO & CRO Market Size, by Development Stage, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Medical Device CDMO & CRO Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 11. Global Medical Device CDMO & CRO Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2025 vs 2032 (%)
FIGURE 13. Global Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Medical Device CDMO & CRO Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Medical Device CDMO & CRO Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Medical Device CDMO & CRO Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Medical Device CDMO & CRO Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Medical Device CDMO & CRO Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Medical Device CDMO & CRO Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Medical Device CDMO & CRO Market Segmentation & Coverage
TABLE 2. Global Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 3. Global Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 4. Global End-to-End CDMO-CRO Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global End-to-End CDMO-CRO Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global End-to-End CDMO-CRO Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Manufacturing + Clinical Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Manufacturing + Clinical Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Manufacturing + Clinical Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Development + Regulatory Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Development + Regulatory Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Development + Regulatory Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 14. Global Preclinical Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Preclinical Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Preclinical Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Clinical Trial Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Clinical Trial Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Clinical Trial Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Commercial Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Commercial Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Commercial Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 24. Global Device Design & Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Device Design & Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Device Design & Engineering Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Clinical Trial Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Clinical Trial Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Clinical Trial Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Regulatory Affairs & Submissions Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Regulatory Affairs & Submissions Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Regulatory Affairs & Submissions Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 34. Global Orthopedics Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Orthopedics Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Orthopedics Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global General Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global General Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global General Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Medical Device CDMO & CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Asia-Pacific Medical Device CDMO & CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Asia-Pacific Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 49. Asia-Pacific Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 52. North America Medical Device CDMO & CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. North America Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 54. North America Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 55. North America Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 56. North America Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 57. Latin America Medical Device CDMO & CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Latin America Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 59. Latin America Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 60. Latin America Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 61. Latin America Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 62. Europe Medical Device CDMO & CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Europe Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 64. Europe Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 65. Europe Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 66. Europe Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 67. Middle East Medical Device CDMO & CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Middle East Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 69. Middle East Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 70. Middle East Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 71. Middle East Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 72. Africa Medical Device CDMO & CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Africa Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 74. Africa Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 75. Africa Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 76. Africa Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 77. Global Medical Device CDMO & CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. ASEAN Medical Device CDMO & CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. ASEAN Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 80. ASEAN Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 81. ASEAN Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 82. ASEAN Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 83. GCC Medical Device CDMO & CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. GCC Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 85. GCC Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 86. GCC Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 87. GCC Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 88. European Union Medical Device CDMO & CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. European Union Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 90. European Union Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 91. European Union Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 92. European Union Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 93. BRICS Medical Device CDMO & CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. BRICS Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 95. BRICS Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 96. BRICS Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 97. BRICS Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 98. G7 Medical Device CDMO & CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. G7 Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 100. G7 Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 101. G7 Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 102. G7 Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 103. NATO Medical Device CDMO & CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. NATO Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 105. NATO Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 106. NATO Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 107. NATO Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 108. Global Medical Device CDMO & CRO Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. United States Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 110. United States Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 111. United States Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 112. United States Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 113. United States Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 114. Canada Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 115. Canada Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 116. Canada Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 117. Canada Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 118. Canada Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 119. Mexico Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 120. Mexico Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 121. Mexico Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 122. Mexico Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 123. Mexico Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 124. Brazil Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 125. Brazil Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 126. Brazil Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 127. Brazil Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 128. Brazil Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 129. United Kingdom Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 130. United Kingdom Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 131. United Kingdom Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 132. United Kingdom Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 133. United Kingdom Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 134. Germany Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 135. Germany Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 136. Germany Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 137. Germany Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 138. Germany Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 139. France Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 140. France Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 141. France Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 142. France Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 143. France Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 144. Russia Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 145. Russia Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 146. Russia Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 147. Russia Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 148. Russia Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 149. Italy Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 150. Italy Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 151. Italy Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 152. Italy Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 153. Italy Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 154. Spain Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 155. Spain Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 156. Spain Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 157. Spain Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 158. Spain Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 159. China Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 160. China Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 161. China Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 162. China Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 163. China Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 164. India Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 165. India Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 166. India Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 167. India Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 168. India Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 169. Japan Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 170. Japan Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 171. Japan Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 172. Japan Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 173. Japan Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 174. Australia Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 175. Australia Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 176. Australia Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 177. Australia Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 178. Australia Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 179. South Korea Medical Device CDMO & CRO Market Size, 2017-2032 (USD Million)
TABLE 180. South Korea Medical Device CDMO & CRO Market Size, by Integrated Service Offering, 2017-2032 (USD Million)
TABLE 181. South Korea Medical Device CDMO & CRO Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 182. South Korea Medical Device CDMO & CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 183. South Korea Medical Device CDMO & CRO Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 184. Global Medical Device CDMO & CRO Market Share, by Key Player, 2025
TABLE 185. Global Medical Device CDMO & CRO Market, Key Experts

Companies Mentioned

  • Avania Clinical Services
  • Charles River Laboratories International, Inc.
  • ClinChoice
  • CMIC Group
  • Eurofins Scientific
  • Fortrea Holdings, Inc.
  • ICON plc
  • IQVIA Holdings, Inc.
  • Medpace Holdings, Inc.
  • NAMSA
  • Parexel International Corporation
  • Proxima CRO
  • Qmed
  • SGS SA
  • Sterling Industries
  • Syneos Health, Inc.
  • Thermo Fisher Scientific Inc.
  • UL Solutions
  • WuXi AppTec Co., Ltd.

Related Topics

Related Reports

Electronic Chemicals CDMO & CRO Market - Global Forecast 2026-2032 - Product Image

Electronic Chemicals CDMO & CRO Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
CDMO Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035) - Product Image

CDMO Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035)

  • Report
  • 350 Pages
  • Global
From
Plasmid DNA CDMO Service Market - Global Forecast 2026-2032 - Product Image

Plasmid DNA CDMO Service Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Pharmaceutical Contract Manufacturing & Research Services Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Contract Manufacturing & Research Services Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Electronic Chemicals CDMO & CRO Market by Type, Scale, Application, End-Use & Region-Global Forecast to 2029 - Product Image

Electronic Chemicals CDMO & CRO Market by Type, Scale, Application, End-Use & Region-Global Forecast to 2029

  • Report
  • 274 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.